$0.25
+0.00 (+0.40%)
Open$0.27
Previous Close$0.25
Day High$0.27
Day Low$0.25
52W High$0.50
52W Low$0.24
Volume—
Avg Volume335.7K
Market Cap25.44M
P/E Ratio—
EPS$-0.07
SectorPharmaceuticals
Analyst Ratings
Strong Buy
6 analysts
Price Target
+6,181.1% upside
Current
$0.25
$0.25
Target
$15.64
$15.64
$13.90
$15.64 avg
$22.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.00M | 1.02M | 13.95M |
| Net Income | -4,771,879 | -4,360,977 | 2.16M |
| Profit Margin | -477.1% | -453.3% | 15.5% |
| EBITDA | -8,532,162 | -8,230,659 | 3.52M |
| Free Cash Flow | — | — | 2.06M |
| Rev Growth | -1.5% | -1.5% | +17.1% |
| Debt/Equity | 0.02 | 0.02 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |